▶ 調査レポート

世界の白血球アフェレーシス市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Leukapheresis Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の白血球アフェレーシス市場 2021:企業別、地域別、種類・用途別 / Global Leukapheresis Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X10286資料のイメージです。• レポートコード:GIR-105X10286
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Medical Devices & Consumables
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、白血球アフェレーシスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。白血球アフェレーシスの種類別市場規模(白血球アフェレーシスデバイス、白血球アフェレーシスディスポーザブル)、用途別市場規模(病院、研究所)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・白血球アフェレーシスの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Asahi Kasei Medical、Fresenius、Haemonetics、Hemacare Corporation、Terumo BCT、Stemcell Technologies、Bioivt
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:白血球アフェレーシスデバイス、白血球アフェレーシスディスポーザブル
・用途別分析2016年-2026年:病院、研究所
・白血球アフェレーシスの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・白血球アフェレーシスのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・白血球アフェレーシスのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・白血球アフェレーシスの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・白血球アフェレーシスの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Leukapheresis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Leukapheresis size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Leukapheresis market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Leukapheresis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Leukapheresis Devices
Leukapheresis Disposables

Market segment by Application can be divided into
Hospitals
Research Institute

The key market players for global Leukapheresis market are listed below:
Asahi Kasei Medical
Fresenius
Haemonetics
Hemacare Corporation
Terumo BCT
Stemcell Technologies
Bioivt

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Leukapheresis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Leukapheresis, with price, sales, revenue and global market share of Leukapheresis from 2019 to 2021.
Chapter 3, the Leukapheresis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leukapheresis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Leukapheresis market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Leukapheresis sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Leukapheresis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Leukapheresis Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Leukapheresis Devices
1.2.3 Leukapheresis Disposables
1.3 Market Analysis by Application
1.3.1 Overview: Global Leukapheresis Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Research Institute
1.4 Global Leukapheresis Market Size & Forecast
1.4.1 Global Leukapheresis Sales in Value (2016-2026))
1.4.2 Global Leukapheresis Sales in Volume (2016-2026)
1.4.3 Global Leukapheresis Price by Type (2016-2026) & (USD/Unit)
1.5 Global Leukapheresis Production Capacity Analysis
1.5.1 Global Leukapheresis Total Production Capacity (2016-2026)
1.5.2 Global Leukapheresis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Leukapheresis Market Drivers
1.6.2 Leukapheresis Market Restraints
1.6.3 Leukapheresis Trends Analysis
2 Manufacturers Profiles
2.1 Asahi Kasei Medical
2.1.1 Asahi Kasei Medical Details
2.1.2 Asahi Kasei Medical Major Business
2.1.3 Asahi Kasei Medical Leukapheresis Product and Services
2.1.4 Asahi Kasei Medical Leukapheresis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Fresenius
2.2.1 Fresenius Details
2.2.2 Fresenius Major Business
2.2.3 Fresenius Leukapheresis Product and Services
2.2.4 Fresenius Leukapheresis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Haemonetics
2.3.1 Haemonetics Details
2.3.2 Haemonetics Major Business
2.3.3 Haemonetics Leukapheresis Product and Services
2.3.4 Haemonetics Leukapheresis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Hemacare Corporation
2.4.1 Hemacare Corporation Details
2.4.2 Hemacare Corporation Major Business
2.4.3 Hemacare Corporation Leukapheresis Product and Services
2.4.4 Hemacare Corporation Leukapheresis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Terumo BCT
2.5.1 Terumo BCT Details
2.5.2 Terumo BCT Major Business
2.5.3 Terumo BCT Leukapheresis Product and Services
2.5.4 Terumo BCT Leukapheresis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Stemcell Technologies
2.6.1 Stemcell Technologies Details
2.6.2 Stemcell Technologies Major Business
2.6.3 Stemcell Technologies Leukapheresis Product and Services
2.6.4 Stemcell Technologies Leukapheresis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bioivt
2.7.1 Bioivt Details
2.7.2 Bioivt Major Business
2.7.3 Bioivt Leukapheresis Product and Services
2.7.4 Bioivt Leukapheresis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Leukapheresis Sales by Manufacturer
3.1 Global Leukapheresis Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Leukapheresis Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Leukapheresis
3.4 Market Concentration Rate
3.4.1 Top 3 Leukapheresis Manufacturer Market Share
3.4.2 Top 6 Leukapheresis Manufacturer Market Share
3.5 Global Leukapheresis Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Leukapheresis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Leukapheresis Market Size by Region
4.1.1 Global Leukapheresis Sales in Volume by Region (2016-2026)
4.1.2 Global Leukapheresis Revenue by Region (2016-2026)
4.2 North America Leukapheresis Revenue (2016-2026)
4.3 Europe Leukapheresis Revenue (2016-2026)
4.4 Asia-Pacific Leukapheresis Revenue (2016-2026)
4.5 South America Leukapheresis Revenue (2016-2026)
4.6 Middle East and Africa Leukapheresis Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Leukapheresis Sales in Volume by Type (2016-2026)
5.2 Global Leukapheresis Revenue by Type (2016-2026)
5.3 Global Leukapheresis Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Leukapheresis Sales in Volume by Application (2016-2026)
6.2 Global Leukapheresis Revenue by Application (2016-2026)
6.3 Global Leukapheresis Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Leukapheresis Sales by Type (2016-2026)
7.2 North America Leukapheresis Sales by Application (2016-2026)
7.3 North America Leukapheresis Market Size by Country
7.3.1 North America Leukapheresis Sales in Volume by Country (2016-2026)
7.3.2 North America Leukapheresis Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Leukapheresis Sales by Type (2016-2026)
8.2 Europe Leukapheresis Sales by Application (2016-2026)
8.3 Europe Leukapheresis Market Size by Country
8.3.1 Europe Leukapheresis Sales in Volume by Country (2016-2026)
8.3.2 Europe Leukapheresis Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Leukapheresis Sales by Type (2016-2026)
9.2 Asia-Pacific Leukapheresis Sales by Application (2016-2026)
9.3 Asia-Pacific Leukapheresis Market Size by Region
9.3.1 Asia-Pacific Leukapheresis Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Leukapheresis Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Leukapheresis Sales by Type (2016-2026)
10.2 South America Leukapheresis Sales by Application (2016-2026)
10.3 South America Leukapheresis Market Size by Country
10.3.1 South America Leukapheresis Sales in Volume by Country (2016-2026)
10.3.2 South America Leukapheresis Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Leukapheresis Sales by Type (2016-2026)
11.2 Middle East & Africa Leukapheresis Sales by Application (2016-2026)
11.3 Middle East & Africa Leukapheresis Market Size by Country
11.3.1 Middle East & Africa Leukapheresis Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Leukapheresis Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Leukapheresis Typical Distributors
12.3 Leukapheresis Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Leukapheresis Revenue by Type, (USD Million), 2021-2026
Table 2. Global Leukapheresis Revenue by Application, (USD Million), 2021-2026
Table 3. Asahi Kasei Medical Basic Information, Manufacturing Base and Competitors
Table 4. Asahi Kasei Medical Major Business
Table 5. Asahi Kasei Medical Leukapheresis Product and Services
Table 6. Asahi Kasei Medical Leukapheresis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Fresenius Basic Information, Manufacturing Base and Competitors
Table 8. Fresenius Major Business
Table 9. Fresenius Leukapheresis Product and Services
Table 10. Fresenius Leukapheresis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Haemonetics Basic Information, Manufacturing Base and Competitors
Table 12. Haemonetics Major Business
Table 13. Haemonetics Leukapheresis Product and Services
Table 14. Haemonetics Leukapheresis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hemacare Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Hemacare Corporation Major Business
Table 17. Hemacare Corporation Leukapheresis Product and Services
Table 18. Hemacare Corporation Leukapheresis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Terumo BCT Basic Information, Manufacturing Base and Competitors
Table 20. Terumo BCT Major Business
Table 21. Terumo BCT Leukapheresis Product and Services
Table 22. Terumo BCT Leukapheresis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 24. Stemcell Technologies Major Business
Table 25. Stemcell Technologies Leukapheresis Product and Services
Table 26. Stemcell Technologies Leukapheresis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bioivt Basic Information, Manufacturing Base and Competitors
Table 28. Bioivt Major Business
Table 29. Bioivt Leukapheresis Product and Services
Table 30. Bioivt Leukapheresis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Leukapheresis Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Leukapheresis Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Leukapheresis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Leukapheresis Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Leukapheresis Production Site of Key Manufacturer
Table 36. Leukapheresis New Entrant and Capacity Expansion Plans
Table 37. Leukapheresis Mergers & Acquisitions in the Past Five Years
Table 38. Global Leukapheresis Sales by Region (2016-2021e) & (K Units)
Table 39. Global Leukapheresis Sales by Region (2021-2026) & (K Units)
Table 40. Global Leukapheresis Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Leukapheresis Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Leukapheresis Sales by Type (2016-2021e) & (K Units)
Table 43. Global Leukapheresis Sales by Type (2021-2026) & (K Units)
Table 44. Global Leukapheresis Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Leukapheresis Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Leukapheresis Price by Type (2016-2021e) & (USD/Unit)
Table 47. Global Leukapheresis Price by Type (2021-2026) & (USD/Unit)
Table 48. Global Leukapheresis Sales by Application (2016-2021e) & (K Units)
Table 49. Global Leukapheresis Sales by Application (2021-2026) & (K Units)
Table 50. Global Leukapheresis Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Leukapheresis Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Leukapheresis Price by Application (2016-2021e) & (USD/Unit)
Table 53. Global Leukapheresis Price by Application (2021-2026) & (USD/Unit)
Table 54. North America Leukapheresis Sales by Country (2016-2021e) & (K Units)
Table 55. North America Leukapheresis Sales by Country (2021-2026) & (K Units)
Table 56. North America Leukapheresis Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Leukapheresis Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Leukapheresis Sales by Type (2016-2021e) & (K Units)
Table 59. North America Leukapheresis Sales by Type (2021-2026) & (K Units)
Table 60. North America Leukapheresis Sales by Application (2016-2021e) & (K Units)
Table 61. North America Leukapheresis Sales by Application (2021-2026) & (K Units)
Table 62. Europe Leukapheresis Sales by Country (2016-2021e) & (K Units)
Table 63. Europe Leukapheresis Sales by Country (2021-2026) & (K Units)
Table 64. Europe Leukapheresis Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Leukapheresis Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Leukapheresis Sales by Type (2016-2021e) & (K Units)
Table 67. Europe Leukapheresis Sales by Type (2021-2026) & (K Units)
Table 68. Europe Leukapheresis Sales by Application (2016-2021e) & (K Units)
Table 69. Europe Leukapheresis Sales by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific Leukapheresis Sales by Region (2016-2021e) & (K Units)
Table 71. Asia-Pacific Leukapheresis Sales by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific Leukapheresis Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Leukapheresis Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Leukapheresis Sales by Type (2016-2021e) & (K Units)
Table 75. Asia-Pacific Leukapheresis Sales by Type (2021-2026) & (K Units)
Table 76. Asia-Pacific Leukapheresis Sales by Application (2016-2021e) & (K Units)
Table 77. Asia-Pacific Leukapheresis Sales by Application (2021-2026) & (K Units)
Table 78. South America Leukapheresis Sales by Country (2016-2021e) & (K Units)
Table 79. South America Leukapheresis Sales by Country (2021-2026) & (K Units)
Table 80. South America Leukapheresis Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Leukapheresis Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Leukapheresis Sales by Type (2016-2021e) & (K Units)
Table 83. South America Leukapheresis Sales by Type (2021-2026) & (K Units)
Table 84. South America Leukapheresis Sales by Application (2016-2021e) & (K Units)
Table 85. South America Leukapheresis Sales by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa Leukapheresis Sales by Country (2016-2021e) & (K Units)
Table 87. Middle East & Africa Leukapheresis Sales by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa Leukapheresis Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Leukapheresis Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Leukapheresis Sales by Type (2016-2021e) & (K Units)
Table 91. Middle East & Africa Leukapheresis Sales by Type (2021-2026) & (K Units)
Table 92. Middle East & Africa Leukapheresis Sales by Application (2016-2021e) & (K Units)
Table 93. Middle East & Africa Leukapheresis Sales by Application (2021-2026) & (K Units)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Leukapheresis Typical Distributors
Table 97. Leukapheresis Typical Customers
List of Figures
Figure 1. Leukapheresis Picture
Figure 2. Global Leukapheresis Sales Market Share by Type in 2020
Figure 3. Leukapheresis Devices
Figure 4. Leukapheresis Disposables
Figure 5. Global Leukapheresis Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Research Institute
Figure 8. Global Leukapheresis Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Leukapheresis Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Leukapheresis Sales (2016-2026) & (K Units)
Figure 11. Global Leukapheresis Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Leukapheresis Production Capacity (2016-2026) & (K Units)
Figure 13. Global Leukapheresis Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Leukapheresis Market Drivers
Figure 15. Leukapheresis Market Restraints
Figure 16. Leukapheresis Market Trends
Figure 17. Global Leukapheresis Sales Market Share by Manufacturer in 2020
Figure 18. Global Leukapheresis Revenue Market Share by Manufacturer in 2020
Figure 19. Leukapheresis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Leukapheresis Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Leukapheresis Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Leukapheresis Sales Market Share by Region (2016-2026)
Figure 23. Global Leukapheresis Revenue Market Share by Region (2016-2026)
Figure 24. North America Leukapheresis Revenue (2016-2026) & (USD Million)
Figure 25. Europe Leukapheresis Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Leukapheresis Revenue (2016-2026) & (USD Million)
Figure 27. South America Leukapheresis Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Leukapheresis Revenue (2016-2026) & (USD Million)
Figure 29. Global Leukapheresis Sales Market Share by Type (2016-2026)
Figure 30. Global Leukapheresis Revenue Market Share by Type (2016-2026)
Figure 31. Global Leukapheresis Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Leukapheresis Sales Market Share by Application (2016-2026)
Figure 33. Global Leukapheresis Revenue Market Share by Application (2016-2026)
Figure 34. Global Leukapheresis Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Leukapheresis Sales Market Share by Type (2016-2026)
Figure 36. North America Leukapheresis Sales Market Share by Application (2016-2026)
Figure 37. North America Leukapheresis Sales Market Share by Country (2016-2026)
Figure 38. North America Leukapheresis Revenue Market Share by Country (2016-2026)
Figure 39. United States Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Leukapheresis Sales Market Share by Type (2016-2026)
Figure 43. Europe Leukapheresis Sales Market Share by Application (2016-2026)
Figure 44. Europe Leukapheresis Sales Market Share by Country (2016-2026)
Figure 45. Europe Leukapheresis Revenue Market Share by Country (2016-2026)
Figure 46. Germany Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Leukapheresis Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Leukapheresis Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Leukapheresis Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Leukapheresis Revenue Market Share by Region (2016-2026)
Figure 55. China Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Leukapheresis Sales Market Share by Type (2016-2026)
Figure 62. South America Leukapheresis Sales Market Share by Application (2016-2026)
Figure 63. South America Leukapheresis Sales Market Share by Country (2016-2026)
Figure 64. South America Leukapheresis Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Leukapheresis Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Leukapheresis Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Leukapheresis Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Leukapheresis Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Leukapheresis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source